Replies to post #380636 on Innovation Pharmaceuticals Inc (IPIX)

[zandant]

Looks like Alfasigma has a new CEO, effective November 1st. Not sure how this will effect B but the last time there was a CEO change involving a potential IPIX partner, the deal, according to Leo, fell through. Maybe this new CEO will move things along at a faster pace.
https://www.alfasigma.com/corporate/change-at-the-top-of-alfasigma-pier-vincenzo-colli-leaves-new-ceo-will-be-francesco-balestrieri/

[loanranger]

In the IPIX 10-K. I linked it earlier and probably should have repeated it.
https://www.sec.gov/Archives/edgar/data/1355250/000147793221006717/ipix_10k.htm#i15 (p.9)

"I hope I am missing something."
I don't think so and I understand your distress, but this is pretty clear:
"Due to a delay at the manufacturing vendor, delivery of drug substance to Alfasigma has moved out (mid 4Q2021), and the subsequent drug product manufacturing time will likely push any clinical trial start into 2022."

I haven't seen much at all out of AS on the trial. As a private company they have limited disclosure requirements.